Teva Offers Drugs Valued at $23 Billion to End Opioid Suits | IndustryWeek
Teva shares tumble as company faces price-fixing lawsuit - The Jerusalem Post
Attorney General Morrisey sues opioid makers Johnson & Johnson, Teva Pharmaceuticals | WBOY.com
What's behind the timed resurgence of lawsuits against Teva? | Ctech
Report: Teva Settles Investor Lawsuit for $420M - Hamodia.com
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva at the center of a lawsuit for raising drug prices - The Jerusalem Post
Teva suffers trial loss in New York's landmark opioid case | FiercePharma
Local generic drug company is 1 of 6 accused by 20 states in price-fixing lawsuit - Philadelphia Business Journal
Teva worked with other drug firms to inflate prices, lawsuit claims - Axios
Teva Pharmaceuticals - Wikipedia
:max_bytes(150000):strip_icc()/TEVA-Chart-05152019-e44e5dbd6f964a0f9d7f5d1ec8c52d6a.png "Teva Hits Fibonacci Support on Concerns Over Lawsuit")
Teva Hits Fibonacci Support on Concerns Over Lawsuit
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva Pharmaceutical says it will defend claims it was involved in price-fixing in the US
Is Biogen stock a buy after Teva settled the Vumerity patent lawsuit? - Rich Picks Daily
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times
Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug | BioSpace
Pfizer gets $2.15 billion settlement
